Follow
Lauwerys B
Lauwerys B
UCB Biopharma
Verified email at ucb.com
Title
Cited by
Cited by
Year
Transancestral mapping and genetic load in systemic lupus erythematosus
CD Langefeld, HC Ainsworth, DSC Graham, JA Kelly, ME Comeau, ...
Nature communications 8 (1), 16021, 2017
3272017
Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18
BR Lauwerys, N Garot, JC Renauld, FA Houssiau
The Journal of Immunology 165 (4), 1847-1853, 2000
2592000
Synovial tissue research: a state-of-the-art review
C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Cañete, ...
Nature Reviews Rheumatology 13 (8), 463-475, 2017
2402017
The anti‐CD20 antibody rituximab reduces the Th17 cell response
FL van de Veerdonk, B Lauwerys, RJ Marijnissen, K Timmermans, ...
Arthritis & Rheumatism 63 (6), 1507-1516, 2011
2322011
Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus
AN Toukap, C Galant, I Theate, AL Maudoux, RJU Lories, FA Houssiau, ...
Arthritis & Rheumatism 56 (5), 1579-1588, 2007
2202007
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
IEA Hoffman, BR Lauwerys, F De Keyser, TWJ Huizinga, D Isenberg, ...
Annals of the rheumatic diseases 68 (3), 412-415, 2009
2142009
Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18
BR Lauwerys, JC Renauld, FA Houssiau
Cytokine 11 (11), 822-830, 1999
2001999
Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid
BR Lauwerys, E Hachulla, F Spertini, E Lazaro, C Jorgensen, X Mariette, ...
Arthritis & Rheumatism 65 (2), 447-456, 2013
1822013
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open …
F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ...
The Lancet 397 (10271), 305-317, 2021
1792021
A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial
F Tamirou, BR Lauwerys, M Dall'Era, M Mackay, B Rovin, R Cervera, ...
Lupus science & medicine 2 (1), e000123, 2015
1742015
Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab …
P Durez, J Malghem, AN Toukap, G Depresseux, BR Lauwerys, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
1612007
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene
SE Löfgren, J Frostegård, L Truedsson, BA Pons-Estel, S D'Alfonso, ...
Genes & Immunity 13 (3), 268-274, 2012
1602012
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
BR Lauwerys, J Ducreux, FA Houssiau
Rheumatology 53 (8), 1369-1376, 2014
1372014
Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
V Badot, C Galant, A Nzeusseu Toukap, I Theate, AL Maudoux, ...
Arthritis research & therapy 11, 1-13, 2009
1252009
Side-effects of intravenous cyclophosphamide pulse therapy
F Martin, B Lauwerys, C Lefebvre, JP Devogelaer, FA Houssiau
Lupus 6 (3), 254-257, 1997
1221997
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
P Raj, E Rai, R Song, S Khan, BE Wakeland, K Viswanathan, C Arana, ...
elife 5, e12089, 2016
1212016
Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature
JCH van der Hilst, M Moutschen, PE Messiaen, BR Lauwerys, ...
Biologics: Targets and Therapy, 75-80, 2016
1152016
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
HI Brunner, N Ruperto, N Tzaribachev, G Horneff, VG Chasnyk, ...
Annals of the rheumatic diseases 77 (1), 21-29, 2018
1132018
Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab
AA Grom, NT Ilowite, V Pascual, HI Brunner, A Martini, D Lovell, ...
Arthritis & Rheumatology 68 (1), 218-228, 2016
1022016
Lack of evidence of stimulatory autoantibodies to platelet‐derived growth factor receptor in patients with systemic sclerosis
JF Classen, D Henrohn, F Rorsman, J Lennartsson, BR Lauwerys, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
1012009
The system can't perform the operation now. Try again later.
Articles 1–20